seed
Stage
2025
Founded
2
Investors
About
Biograil develops an oral drug delivery device designed to enable the oral administration of large molecule drugs, which are typically given via injection. This technology aims to improve patient adherence and quality of life.
Explore Biograil's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.